Dogwood Therapeutics DWTX Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Dogwood Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's return on equity?
- Dogwood Therapeutics (DWTX) reported return on equity of -64.6% in Q1 2026.
- How has Dogwood Therapeutics's return on equity changed year-over-year?
- Dogwood Therapeutics's return on equity increased by 85.7% year-over-year, from -451.3% to -64.6%.
- What is the long-term trend for Dogwood Therapeutics's return on equity?
- Over 2 years (2021 to 2023), Dogwood Therapeutics's return on equity has grown at a 15.1% compound annual growth rate (CAGR), from -71.8% to -95.1%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.